Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Impact of acute handling stress, anaesthesia, and euthanasia on fish plasma biochemistry: implications for veterinary screening and metabolomic sampling.

Young T, Walker SP, Alfaro AC, Fletcher LM, Murray JS, Lulijwa R, Symonds J.

Fish Physiol Biochem. 2019 Jun 25. doi: 10.1007/s10695-019-00669-8. [Epub ahead of print]

PMID:
31240506
2.

Acetazolamide Treatment Prevents Redistribution of Astrocyte Aquaporin 4 after Murine Traumatic Brain Injury.

Glober NK, Sprague S, Ahmad S, Mayfield KG, Fletcher LM, Digicaylioglu MH, Sayre NL.

Neurosci J. 2019 May 2;2019:2831501. doi: 10.1155/2019/2831501. eCollection 2019.

3.

Effect of substrate deployment timing and reproductive strategy on patterns in invasiveness of the colonial ascidian Didemnum vexillum.

Fletcher LM, Atalah J, Forrest BM.

Mar Environ Res. 2018 Oct;141:109-118. doi: 10.1016/j.marenvres.2018.08.006. Epub 2018 Aug 7.

PMID:
30119919
4.

Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults.

Renzi-Hammond LM, Bovier ER, Fletcher LM, Miller LS, Mewborn CM, Lindbergh CA, Baxter JH, Hammond BR.

Nutrients. 2017 Nov 14;9(11). pii: E1246. doi: 10.3390/nu9111246.

5.

Wanted dead or alive? Using metabarcoding of environmental DNA and RNA to distinguish living assemblages for biosecurity applications.

Pochon X, Zaiko A, Fletcher LM, Laroche O, Wood SA.

PLoS One. 2017 Nov 2;12(11):e0187636. doi: 10.1371/journal.pone.0187636. eCollection 2017.

6.

It's a wrap: encapsulation as a management tool for marine biofouling.

Atalah J, Brook R, Cahill P, Fletcher LM, Hopkins GA.

Biofouling. 2016;32(3):277-86. doi: 10.1080/08927014.2015.1137288.

PMID:
26919588
7.

Desiccation as a mitigation tool to manage biofouling risks: trials on temperate taxa to elucidate factors influencing mortality rates.

Hopkins GA, Prince M, Cahill PL, Fletcher LM, Atalah J.

Biofouling. 2016;32(1):1-11. doi: 10.1080/08927014.2015.1115484.

PMID:
26691450
8.

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.

Irvine KM, Wockner LF, Shanker M, Fagan KJ, Horsfall LU, Fletcher LM, Ungerer JP, Pretorius CJ, Miller GC, Clouston AD, Lampe G, Powell EE.

Liver Int. 2016 Mar;36(3):370-7. doi: 10.1111/liv.12896. Epub 2015 Aug 28.

PMID:
26104018
9.

Authors' response.

Fletcher LM, Engles M, Hammond BR Jr.

Optom Vis Sci. 2015 Mar;92(3):e82. doi: 10.1097/OPX.0000000000000489. No abstract available.

PMID:
25945962
10.

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity.

Fagan KJ, Pretorius CJ, Horsfall LU, Irvine KM, Wilgen U, Choi K, Fletcher LM, Tate J, Melino M, Nusrat S, Miller GC, Clouston AD, Ballard E, O'Rourke P, Lampe G, Ungerer JP, Powell EE.

Liver Int. 2015 Jun;35(6):1673-81. doi: 10.1111/liv.12760. Epub 2015 Jan 20.

PMID:
25495373
11.

A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.

Hammond BR, Fletcher LM, Roos F, Wittwer J, Schalch W.

Invest Ophthalmol Vis Sci. 2014 Dec 2;55(12):8583-9. doi: 10.1167/iovs.14-15573.

PMID:
25468896
12.

Visibility through atmospheric haze and its relation to macular pigment.

Fletcher LM, Engles M, Hammond BR Jr.

Optom Vis Sci. 2014 Sep;91(9):1089-96. doi: 10.1097/OPX.0000000000000355.

PMID:
25148065
13.

Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers.

Fagan KJ, Irvine KM, McWhinney BC, Fletcher LM, Horsfall LU, Johnson L, O'Rourke P, Martin J, Scott I, Pretorius CJ, Ungerer JP, Powell EE.

BMC Gastroenterol. 2014 May 22;14:97. doi: 10.1186/1471-230X-14-97.

14.

Effects of long-term hepatic ischemia-reperfusion injury on the function of P-glycoprotein in vivo in rats.

Thorling CA, Roberts MS, Liu X, Fletcher LM, Crawford D, Burczynski FJ.

J Pharm Pharm Sci. 2014;17(1):121-35.

15.

Predation limits spread of Didemnum vexillum into natural habitats from refuges on anthropogenic structures.

Forrest BM, Fletcher LM, Atalah J, Piola RF, Hopkins GA.

PLoS One. 2013 Dec 12;8(12):e82229. doi: 10.1371/journal.pone.0082229. eCollection 2013.

16.

Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury.

Tan TC, Crawford DH, Jaskowski LA, Subramaniam VN, Clouston AD, Crane DI, Bridle KR, Anderson GJ, Fletcher LM.

Lab Invest. 2013 Dec;93(12):1295-312. doi: 10.1038/labinvest.2013.121. Epub 2013 Oct 14.

17.

BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin.

Fagan KJ, Irvine KM, McWhinney BC, Fletcher LM, Horsfall LU, Johnson LA, Clouston AD, Jonsson JR, O'Rourke P, Martin J, Pretorius CJ, Ungerer JP, Powell EE.

Alcohol Clin Exp Res. 2013 Oct;37(10):1771-8. doi: 10.1111/acer.12143. Epub 2013 Jul 22.

PMID:
23875541
18.

Intravital multiphoton microscopy can model uptake and excretion of fluorescein in hepatic ischemia-reperfusion injury.

Thorling CA, Liu X, Burczynski FJ, Fletcher LM, Roberts MS, Sanchez WY.

J Biomed Opt. 2013 Oct;18(10):101306. doi: 10.1117/1.JBO.18.10.101306.

PMID:
23812606
19.

A corn oil-based diet protects against combined ethanol and iron-induced liver injury in a mouse model of hemochromatosis.

Tan TC, Crawford DH, Jaskowski LA, Murphy TL, Santrampurwala N, Crane D, Clouston AD, Subramaniam VN, Anderson GJ, Fletcher LM.

Alcohol Clin Exp Res. 2013 Oct;37(10):1619-31. doi: 10.1111/acer.12155. Epub 2013 Jun 6.

PMID:
23742171
20.

Glare disability, photostress recovery, and chromatic contrast: relation to macular pigment and serum lutein and zeaxanthin.

Hammond BR Jr, Fletcher LM, Elliott JG.

Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):476-81. doi: 10.1167/iovs.12-10411.

PMID:
23211814
21.

Influence of the dietary carotenoids lutein and zeaxanthin on visual performance: application to baseball.

Hammond BR Jr, Fletcher LM.

Am J Clin Nutr. 2012 Nov;96(5):1207S-13S. doi: 10.3945/ajcn.112.034876. Epub 2012 Oct 10. Review.

PMID:
23053558
22.

The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis.

Tan TC, Crawford DH, Franklin ME, Jaskowski LA, Macdonald GA, Jonsson JR, Watson MJ, Taylor PJ, Fletcher LM.

Liver Int. 2012 Oct;32(9):1391-9. doi: 10.1111/j.1478-3231.2012.02828.x. Epub 2012 Jun 7.

PMID:
22676252
23.

Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Li P, Robertson TA, Zhang Q, Fletcher LM, Crawford DH, Weiss M, Roberts MS.

Pharm Res. 2012 Jun;29(6):1658-69. doi: 10.1007/s11095-012-0690-z.

PMID:
22302523
24.

Multiphoton microscopy can visualize zonal damage and decreased cellular metabolic activity in hepatic ischemia-reperfusion injury in rats.

Thorling CA, Liu X, Burczynski FJ, Fletcher LM, Gobe GC, Roberts MS.

J Biomed Opt. 2011 Nov;16(11):116011. doi: 10.1117/1.3647597.

PMID:
22112116
25.

Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.

Tan TC, Crawford DH, Jaskowski LA, Murphy TM, Heritage ML, Subramaniam VN, Clouston AD, Anderson GJ, Fletcher LM.

Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G865-76. doi: 10.1152/ajpgi.00150.2011. Epub 2011 Aug 4.

26.

Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.

Li P, Robertson TA, Thorling CA, Zhang Q, Fletcher LM, Crawford DH, Roberts MS.

Drug Metab Dispos. 2011 Apr;39(4):571-9. doi: 10.1124/dmd.110.036806. Epub 2011 Jan 18.

PMID:
21245286
27.

Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model.

Zou YH, Liu X, Khlentzos AM, Asadian P, Li P, Thorling CA, Robertson TA, Fletcher LM, Crawford DH, Roberts MS.

Drug Metab Pharmacokinet. 2010;25(5):442-9. Epub 2010 Sep 22.

28.

Serum ferritin concentration predicts mortality in patients awaiting liver transplantation.

Walker NM, Stuart KA, Ryan RJ, Desai S, Saab S, Nicol JA, Fletcher LM, Crawford DH.

Hepatology. 2010 May;51(5):1683-91. doi: 10.1002/hep.23537.

PMID:
20225256
29.

Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.

Bridle KR, Popa C, Morgan ML, Sobbe AL, Clouston AD, Fletcher LM, Crawford DH.

Liver Transpl. 2009 Oct;15(10):1315-24. doi: 10.1002/lt.21804.

30.

Hepcidin regulation in wild-type and Hfe knockout mice in response to alcohol consumption: evidence for an alcohol-induced hypoxic response.

Heritage ML, Murphy TL, Bridle KR, Anderson GJ, Crawford DH, Fletcher LM.

Alcohol Clin Exp Res. 2009 Aug;33(8):1391-400. doi: 10.1111/j.1530-0277.2009.00969.x. Epub 2009 May 4.

PMID:
19426170
31.

Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.

Crawford DH, Murphy TL, Ramm LE, Fletcher LM, Clouston AD, Anderson GJ, Subramaniam VN, Powell LW, Ramm GA.

Hepatology. 2009 Feb;49(2):418-25. doi: 10.1002/hep.22650.

PMID:
19177571
32.

Head and neck tumour immunology: basic concepts and new clinical implications.

Topping KP, Fletcher LM, Agada FO, Alhamarneh O, Stafford ND, Greenman J.

J Laryngol Otol. 2009 Jan;123(1):9-18. doi: 10.1017/S0022215108003368. Epub 2008 Sep 2. Review.

PMID:
18761764
33.

Cell-specific location of Hfe: It is the 'cyte that matters.

Crawford DH, Fletcher LM, Anderson GJ.

Hepatology. 2008 Jul;48(1):336-8. doi: 10.1002/hep.22427. No abstract available.

PMID:
18571786
34.

Patient-focused outcomes following detection in a hospital-based screening programme for C282Y haemochromatosis.

McCullen MA, Fletcher LM, Dimeski G, Pink A, Powell LW, Crawford DH, Hickman PE.

Intern Med J. 2008 Aug;38(8):651-6. doi: 10.1111/j.1445-5994.2007.01578.x. Epub 2008 Feb 17.

PMID:
18284459
35.

Screening for hemochromatosis in asymptomatic subjects with or without a family history.

Powell LW, Dixon JL, Ramm GA, Purdie DM, Lincoln DJ, Anderson GJ, Subramaniam VN, Hewett DG, Searle JW, Fletcher LM, Crawford DH, Rodgers H, Allen KJ, Cavanaugh JA, Bassett ML.

Arch Intern Med. 2006 Feb 13;166(3):294-301.

PMID:
16476869
36.

Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease.

Bridle K, Cheung TK, Murphy T, Walters M, Anderson G, Crawford DG, Fletcher LM.

Alcohol Clin Exp Res. 2006 Jan;30(1):106-12.

PMID:
16433737
37.

Steatosis is a cofactor in liver injury in hemochromatosis.

Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, Fletcher LM, Powell LW, Jonsson JR.

Gastroenterology. 2005 Dec;129(6):1937-43.

PMID:
16344062
38.

Ferroportin disease due to the A77D mutation in Australia.

Subramaniam VN, Wallace DF, Dixon JL, Fletcher LM, Crawford DH.

Gut. 2005 Jul;54(7):1048-9. No abstract available.

39.

Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles.

Berwick DC, Dell GC, Welsh GI, Heesom KJ, Hers I, Fletcher LM, Cooke FT, Tavaré JM.

J Cell Sci. 2004 Dec 1;117(Pt 25):5985-93. Epub 2004 Nov 16.

40.

Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.

Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, Jeffrey GP, McCaughan GW, Kerlin P, Powell LW, Elias EE.

Hepatology. 2004 Jun;39(6):1655-62.

PMID:
15185307
41.

Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis.

Stuart KA, Anderson GJ, Frazer DM, Murphy TL, Powell LW, Fletcher LM, Crawford DH.

Hepatology. 2004 Feb;39(2):492-9.

PMID:
14768003
42.

Hemochromatosis and alcoholic liver disease.

Fletcher LM, Powell LW.

Alcohol. 2003 Jun;30(2):131-6. Review.

PMID:
12957297
43.

Effect of alcohol on iron storage diseases of the liver.

Fletcher LM, Bridle KR, Crawford DH.

Best Pract Res Clin Gastroenterol. 2003 Aug;17(4):663-77. Review.

PMID:
12828961
44.

Duodenal expression of iron transport molecules in untreated haemochromatosis subjects.

Stuart KA, Anderson GJ, Frazer DM, Powell LW, McCullen M, Fletcher LM, Crawford DH.

Gut. 2003 Jul;52(7):953-9.

45.

Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis.

Bridle KR, Crawford DH, Fletcher LM, Smith JL, Powell LW, Ramm GA.

J Hepatol. 2003 Apr;38(4):426-33.

PMID:
12663233
46.

Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening.

Whiting PW, Fletcher LM, Dixon JK, Gochee P, Powell LW, Crawford DH.

J Hepatol. 2002 Sep;37(3):309-14.

PMID:
12175625
47.

Functional consequence of targeting protein kinase B/Akt to GLUT4 vesicles.

Ducluzeau PH, Fletcher LM, Welsh GI, Tavaré JM.

J Cell Sci. 2002 Jul 15;115(Pt 14):2857-66.

48.

Molecular mechanisms of insulin-stimulated glucose uptake in adipocytes.

Ducluzeau PH, Fletcher LM, Vidal H, Laville M, Tavaré JM.

Diabetes Metab. 2002 Apr;28(2):85-92. Review.

PMID:
11976560
50.

Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.

Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH.

Gastroenterology. 2002 Feb;122(2):281-9.

PMID:
11832443

Supplemental Content

Loading ...
Support Center